[ad_1]
- ImmunoPrecise Antibodies (NASDAQ:IPA) acquired a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq Listing Rules for continued itemizing on the Nasdaq.
- The notification letter doesn’t influence the corporate’s itemizing or buying and selling of the corporate’s frequent shares on Nasdaq right now.
[ad_2]
Source: Seekingalpha